Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 97

1.

Hormone replacement therapy for the primary prevention of chronic diseases: recommendation statement from the Canadian Task Force on Preventive Health Care.

Wathen CN, Feig DS, Feightner JW, Abramson BL, Cheung AM; Canadian Task Force on Preventive Health Care.

CMAJ. 2004 May 11;170(10):1535-7. No abstract available.

2.
3.
4.
6.

Postmenopausal hormone replacement therapy for the primary prevention of chronic conditions: recommendations and rationale.

Berg AO; U.S. Preventive Services Task Force.

Am J Nurs. 2003 Jun;103(6):83-91. Review. No abstract available.

PMID:
12802162
7.

Menopausal hormone therapy for the primary prevention of chronic conditions: a systematic review to update the U.S. Preventive Services Task Force recommendations.

Nelson HD, Walker M, Zakher B, Mitchell J.

Ann Intern Med. 2012 Jul 17;157(2):104-13. doi: 10.7326/0003-4819-157-2-201207170-00466. Review.

PMID:
22786830
8.

Postmenopausal hormone replacement therapy for primary prevention of cardiovascular and cerebrovascular disease. Recommendation statement from the Canadian Task Force on Preventive Health Care.

Abramson BL; Canadian Task Force on Preventive Health Care.

CMAJ. 2004 Apr 27;170(9):1388-9. No abstract available. Erratum in: CMAJ. 2004 May 25;170(11):1650.

9.

Postmenopausal hormone replacement therapy: scientific review.

Nelson HD, Humphrey LL, Nygren P, Teutsch SM, Allan JD.

JAMA. 2002 Aug 21;288(7):872-81. Review.

PMID:
12186605
10.

Postmenopausal hormone replacement therapy for primary prevention of chronic conditions: recommendations and rationale.

U.S. Preventive Services Task Force.

Ann Intern Med. 2002 Nov 19;137(10):834-9.

PMID:
12435221
11.
12.

Prevention of osteoporosis and osteoporotic fractures in postmenopausal women: recommendation statement from the Canadian Task Force on Preventive Health Care.

Cheung AM, Feig DS, Kapral M, Diaz-Granados N, Dodin S; Canadian Task Force on Preventive Health Care.

CMAJ. 2004 May 25;170(11):1665-7. No abstract available.

13.
14.

Women's health. The vanishing promises of hormone replacement.

Enserink M.

Science. 2002 Jul 19;297(5580):325-6. No abstract available.

PMID:
12130763
15.

Compliance with hormone replacement therapy: are women receiving the full impact of hormone replacement therapy preventive health benefits?

Ravnikar VA.

Womens Health Issues. 1992 Summer;2(2):75-80; discussion 80-2. No abstract available.

PMID:
1617309
16.

[Preventive activities in climacteric].

Lopéz GF, Bailón ME, Landa GJ, Fuentes P, Ojuel SJ.

Aten Primaria. 2003 Dec;32 Suppl 2:133-42. Spanish. No abstract available.

PMID:
15116479
17.

[Risks and benefits of postmenopausal hormone replacement therapy].

Szántó F.

Orv Hetil. 1998 Nov 1;139(44):2639-42. Hungarian.

PMID:
9842237
18.

[The story of the reversal of opinion about hormone replacement therapy and cardiovascular disease].

Løkkegaard EC.

Ugeskr Laeger. 2005 Mar 7;167(10):1166-70. Danish. No abstract available.

PMID:
15810574
19.

Hormone therapy--weighing up the evidence.

Teede HJ.

Aust Fam Physician. 2004 Nov;33(11):875-80. Review.

20.

Menopausal hormone therapy: is it OK after all? Weighing symptom relief against the risk.

[No authors listed]

Health After 50 Sci Am Consum Health. 2016 Winter;27(14):3-5. No abstract available.

PMID:
27062750

Supplemental Content

Support Center